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Innate lymphoid cells are present at mucosal sites and represent the first immune barrier against infections, but what contributes to
their circulation and homing is still unclear. Using Rag2−/−Cxcr6Gfp/+ reporter mice, we assessed the expression and role of CXCR6
in the circulation of ILC precursors and their progeny. We identify CXCR6 expressing ILC precursors in the bone marrow and
characterize their significant increase in CXCR6-deficientmice at steady state, indicating their partial retention in the bonemarrow
after CXCR6 ablation. Circulation was also impaired during embryonic life as fetal liver from CXCR6-deficient embryos displayed
decreased numbers of ILC3 precursors. When injected, fetal CXCR6-deficient ILC3 precursors also fail to home and reconstitute
ILC compartments in vivo. We show that adult intestinal ILC subsets have heterogeneous expression pattern of CXCR6, integrin
𝛼
4
𝛽
7
, CD62L, CD69, and CD44, with ILC1 and ILC3 being more likely tissue resident lymphocytes. Intestinal ILC subsets were
unchanged in percentages and numbers in both mice. We demonstrate that the ILC frequency is maintained due to a significant
increase of ILC peripheral proliferation, as well as an increased proliferation of the in situ ILC precursors to compensate their
retention in the bone marrow.
1. Introduction
The family of innate lymphoid cells (ILCs) concerns cells
devoid of rearranged antigen receptors. It comprises con-
ventional EOMES expressing NK (cNK) cells and the helper
subsets composed of three groups (ILC1, ILC2, and ILC3) in
analogy with the T-helper cell nomenclature [1]. ILC1 desig-
nates the group of T-bet expressing cells that are producing
the IFN𝛾 whereas ILC2 includes ROR𝛼/GATA3 dependent
cells producing type Th2 cytokines. ILC3 includes different
subsets that are all ROR𝛾t dependent and produce IL-17
and/or IL-22 (for review, see [2]). In the intestine, the ILC3
populations constantly interact with the microbiota, dietary
compounds, epithelial factors, and cytokines to preserve the
epithelial barrier integrity. IL-22 producing cells from the
ILC3 group mainly concerns the subset that expresses the
NK cell receptor NKp46 (termed NCR+ ILC3). In mice, this
intestinal subset has been shown to protect against infection
with the pathogen Citrobacter rodentium [3–5]. NCR+ ILC3
cells are CCR6− and do not produce IL-17A. They are rare in
cryptopatches compared to CD4+ ILC3 (LTi–like) cells that
express CCR6 and produce IL-17A. This LTi–like subset is
the adult counterpart of the LTi cells present during fetal
life and is crucial for the development of lymph nodes (LN)
and Peyer’s patches. A third subset of double negative (CD4−
NKp46−) ILC3 is also present in the lamina propria. It is
usually denominated by NCR−ILC3 [6–8]. Intestinal ILC2
populations are crucial against parasitic infections [9–11] and
may also be implicated in the regulation of gut homeostasis
by limiting the inflammation [12].
Themigration of lymphocytes to specific tissues is driven
by the upregulation of adhesion and chemokine receptors.
The T lymphocytes are imprinted with specific trafficking
programs that are currently well known [13]. However,
little is known concerning the circulation of ILC and their
progenitors. All ILC groups derive from a bone marrow
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(BM) precursor that expresses the ID2 transcription factor
and the common 𝛾 chain of the interleukin 2 receptor [2].
Initial steps of ILC development start in the bone marrow.
Intestinal lamina propria and spleen could also support the
late stages of ILC differentiation, especially for the ILC3
lineage since precursors are unable to upregulate ROR𝛾t
in the bone marrow [14]. Using mice bearing a targeted
insertion of a GFP-reporter into the Cxcr6 locus (Cxcr6Gfp/+
mice) [15], we have previously shown that a subset of ILC
precursors both in the adult bone marrow and fetal liver
expresses CXCR6 [14]. CXCR6 has also been described as
expressed by most of the ILC intestinal subsets [16]. Homing
and trafficking are achieved by a specific combination of
adhesion molecules and chemokine receptors, and CXCR6
expression could be critical and correlated with differential
homing and/or function of ILC subsets. It has been shown, for
example, that hepatic NK cells rely on CXCR6 expression for
the persistence of memory NK cells [17]. Hence, we decided
to evaluate the role of CXCR6 in the circulation of both ILC
progenitors and ILC subsets.
In this study, we assess the effect of CXCR6 deficiency
on ILC precursors and ILC subsets from the bone mar-
row, intestinal lamina propria (LP), and mesenteric lymph
nodes (mLN). The effect of CXCR6 loss could be ana-
lyzed using the Rag2−/− Cxcr6Gfp/Gfp mouse model since
the GFP reporter insertion simultaneously inactivates the
corresponding Cxcr6 allele [15], and Rag2 deletion ensures a
proper ILC analysis devoid of T-cell contamination. We have
observed an increased percentage of bone marrow CXCR6+
ILC precursors without any concomitant proliferation of
those precursors, nor loss of differentiation potential, which
suggests active bonemarrow retention of ILC precursors after
the CXCR6 loss. Similarly, CXCR6 contributes to circulation
of fetal ILC3 precursors in the fetal liver (FL) as CXCR6-
deficient fetal livers were partially depleted of ILC3 precur-
sors. Using injection and reconstitution analysis, we show
that CXCR6 is required for circulation of ILC3 precursors to
intestinal LP or liver.
We show that pattern expression of CXCR6 and integrin
𝛼
4
𝛽
7
and egress or circulationmarkers such as CD62L, CD69,
and CD44 among ILC are heterogeneous and only intestinal
ILC1 and ILC3 subsets were more likely to be tissue resident
ILC populations. Finally, we show that CXCR6-deficiency
does not alter the homeostatic balance of intestinal ILC
subsets. However, those subsets were seeded and enriched
in dividing and recently divided cells when CXCR6 defi-
ciency occurs. The bone marrow derived ILC progenitor was
similarly highly active and proliferative in CXCR6-deficient
intestinal lamina propria, showing that this high proliferative
state compensates retention of the bone marrow precursors.
2. Materials and Methods
2.1.Mice. Rag2−/−Cxcr6+/+,Rag2−/−Cxcr6Gfp/+,Rag2−/−Cxcr6Gfp/Gfp,
Cxcr6Gfp/+Id2Yfp/+, and Ly5.1 Rag2−/−𝛾c−/− mice were bred
in the animal facilities at Pasteur Institute, Paris. Mice were
cared for in accordance with Pasteur Institute guidelines
in compliance with European animal welfare regulations,
and all animal studies were approved by Pasteur Institute
Safety Committee in accordance with French and European
guidelines.
2.2. Cell Preparation. Bone marrows (BM) were flushed out
of femurs and tibias; mesenteric lymph nodes (mLN), fetal
livers (FL), and fetal spleens (FS) were mechanically dissoci-
ated to obtain cell suspensions. Additionally, BM red blood
cells were lysed by incubation with ammonium chloride-
potassium bicarbonate solution. Cells from BM, mLN, and
FL were magnetically depleted of Lin+ cells via staining with
biotin labeled antibodies to lineage markers, followed by the
use of Streptavidin MicroBeads (Miltenyi).
Small intestine was washed from its contents by PBS
injection, and Peyer’s patches, if present, were removed. After
being cut open longitudinally, small intestine was cut in
1 cm fragments. Fragments of small intestine were incubated
30min at 37∘ and 5%CO
2
in RPMImedium (Gibco) plus 20%
fetal calf serum (FCS),HEPES buffer (10 𝜇M, Sigma-Aldrich),
and then vortexed thoroughly for 4 minutes for removal of
epithelial cells and intraepithelial lymphocytes. Remaining
fragments of small intestine were incubated 30min at 37∘
and 5% CO
2
in RPMI medium plus 20% FCS, HEPES
Buffer (10 𝜇M), and collagenase typeVIII (250 𝜇g/mL, Sigma)
for the isolation of LP lymphocytes. Cell suspension was
centrifuged, resuspended in a 40% solution of Percoll (GE
Healthcare), and underlaid with a 75% solution of Percoll.
After centrifugation 20min at 600 g, cells were collected at
the 40–75% interface.
All cells were then collected in cold HBSS (Gibco) plus
1% FCS. Cell suspensions were counted onMalassez cell, and
dead cells were excluded using Trypan Blue.
2.3. Flow Cytometry. After antibody staining, cells were
washed and dead cells were excluded by Propidium Iodide
staining (250 ng/mL, Sigma-Aldrich). Cells were stained
intracellularly using Foxp3 Permeabilzation/Fixation Kit
according to manufacturers notice (eBiosciences). Cells were
then incubated for 5min with DAPI (4,6-diamidino-2-
phenylindole, 2 𝜇g/mL, Life Technologies), and washed prior
to cell acquisition. FACSCanto II and LSR Fortessa (BD
Biosciences) were used for flow cytometry acquisition, with
Diva6 software (BD Biosciences), and analyzed with FlowJo
v8 software (TreeStar). For visual purposes, only 8000 events
maximum are shown in each FACS dot plot.
Cells were purified with a FACSAria III sorter (BD
Biosciences). Cells were recovered in PBS for cell injection,
or OPTIMEM (Gibco) plus 10% FCS for cell culture.
2.4. Antibodies. Streptavidin was coupled to PECy5. The
following antibodies were either biotinylated or coupled to
fluorochromes (Alexa488, PerCPCy5.5, PE, PECy7, APC,
Alexa 660, APCCy7, BV421, eFluor 450, HZ V500, BV605,
BV650, BV711, BV786): Ly76 (TER-119), Gr-1 (RB6-8C5),
CD11c (HL3), CD3𝜀 (145-2C11), CD19 (6D5), CD8𝛼 (53-
6.7), CD5 (53-7.3), TCR𝛽 (H57-597), TCR𝛾𝛿 (GL-3), NK1.1
(PK136), NKp46 (29A1.4), IL-7R𝛼 (A7R34), c-Kit (2B8), Sca-
1 (D7), 𝛼
4
𝛽
7
(DATK32), Flt3 (A2F10), CD4 (GK1.5), CD45.2
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(104), Thy1.2 (53-2.1), ICOS (C398.4A), CD62L (MEL-14),
CD69 (H1.2F3), CD44 (IM7), ROR𝛾t (AFKJS-9 or Q31-378),
Gata3 (L50-823), human/mouse Ki67 (B56).
Lineage cocktails consisted of
BM: CD3𝜀, CD5, CD8, CD11c, CD19, TCR𝛽, TCR𝛾𝛿,
Ter119, Gr1, and NK1.1,
FL and FS: CD3𝜀, CD11c, CD19, Ter119, Gr1, and
NK1.1,
MLN and LPL: CD3𝜀, CD5, CD8, CD11c, CD19,
TCR𝛽, TCR𝛾𝛿, Ter119, and Gr1.
All antibodies were purchased from BD Biosciences, eBiosi-
cences, or Biolegend.
2.5. Cell Culture. OP9-DL4 stromal cells were plated one day
prior to culture experiment in culture medium: OPTIMEM,
10% FCS, 𝛽-Mercaptoethanol (500 𝜇M, Gibco), penicillin
(5U/mL, Gibco), and streptomycin (5 𝜇g/mL, Gibco). Bone
marrow precursors were FACS sorted in 400 𝜇L of culture
medium and plated on OP9-DL4 cells at 20 cells per well.
Medium was complemented with in-lab produced cytokines
(IL-7, c-KitL and Flt3-L). Cells were cultured for 10 days at
37∘Cand 5%CO
2
and then harvested and stained for analysis.
2.6. In Vivo Reconstitution. Ly5.1 Rag2−/−𝛾c−/− mice were
nonlethally irradiated (900 rad) at least 4 hours prior to
cell injection. Between 1000 and 2000 Lin− CD4hi IL-7R𝛼+
CXCR6+ cells from fetal spleens obtained from either E15.5
Cxcr6Gfp/+ or Cxcr6Gfp/Gfp embryos were sorted in 100 𝜇L of
PBS, and retroorbital injection was performed. Mice were
analyzed 4 weeks after injection.
2.7. Statistical Analysis. All data were submitted to Student’s
unpaired bilateral 𝑡-test. Data were deemed significantly
different when ∗𝑝 < 0.05, ∗∗𝑝 < 0.01, or ∗∗∗𝑝 < 0.005.
3. Results
3.1. CXCR6-Deficient ILC Precursors Are Retained in the Bone
Marrow. We first characterized the BM lymphoid precur-
sor compartments by crossing and analyzing adult Id2Yfp/+
Cxcr6Gfp/+ bonemarrow cells [15, 18]. As previously described
[14, 19, 20], Lin− IL-7R𝛼+ compartment comprises ILC2
precursors (ILC2P) that are Sca-1hi c-Kitlo and lymphoid
Sca-1−/lo c-Kitmed precursors that are divided into common
lymphoid progenitors (CLP; Flt3+ 𝛼
4
𝛽
7
−) and 𝛼
4
𝛽
7
express-
ing lymphoid precursors (Flt3− 𝛼
4
𝛽
7
+). The latter expresses
ID2 (thus representing ILC precursors or ILCP), as well as
ILC2P compartment whereas CLP cells have no expression
of ID2. We observe that ILCP and ILC2P comprised both
CXCR6+ and CXCR6− fractions (Figure 1(a)). CXCR6hi cells
are only found in ILC2P fraction (up to 60%).
To confirm the ILC potential of the two different ILCP
subsets (CXCR6+ and CXCR6−), we cultured them on OP9-
DL4 stromal cell lines with cytokines to promote cell survival
and differentiation (IL-7, c-KitL, and Flt3-L) and analyzed
their progeny after 10 days of culture. We confirmed that
both CXCR6+ and CXCR6− ILCP cells were able to give
rise to ILC1 (ID2+ NKp46+ NK1.1+), ILC3 (ID2+ NKp46−
NK1.1− IL-7R𝛼+ ROR𝛾t+), and ILC2 (ID2+ NKp46− NK1.1−
IL-7R𝛼+ ROR𝛾t−) cells (Figure 1(b)). Interestingly, all ILCs
that were obtained expressed variable levels of CXCR6.
ILC1 progeny cells were distributed between CXCR6− and
CXCR6hi levels, with a majority of CXCR6int cells, regardless
of their progenitor (CXCR6+ or CXCR6− ILCP), showing
that ILC1 could acquire or loose CXCR6 expression. Amongst
remaining non-ILC1 cells, all cells are ID2+ and are enriched
in CXCR6hi cells (up to 77%), but for a smaller fraction that
is CXCR6−. Because in our previous work, we showed that
all ROR𝛾t+ cells (which represent between 30% and 50% in
NK1.1− NKp46− fraction after culture of ILCP, Figure 1(b))
were comprised of CXCR6hi cells, and the remaining ID2+
IL-7R𝛼+ ILC2 cells are both CXCR6hi and CXCR6−, recapit-
ulating the phenotype of ex vivo bone marrow ILC2P.
We analyzed then the contribution of CXCR6 to dif-
ferent lymphoid precursor compartments, using Rag2−/−
Cxcr6+/+ (wt),Cxcr6Gfp/+ (HZ), orCxcr6Gfp/Gfp (KO)mice. As
expected, CLP compartment that does not express CXCR6
was not affected by Cxcr6 deletion either in frequency or
in numbers. No difference was observed for total num-
bers of ILCP and ILC2P in CXCR6-deficient bone marrow
(Figure 2(a)). Levels of CXCR6-GFP between HZ and KO
micewere not different (Figure 2(b)). However, when looking
at the enrichment in CXCR6 expressing cells, a significant
increase of CXCR6+ precursors is detected in both ILCP
and ILC2P subsets (Figure 2(c)). ILCP from both HZ and
KO mice were able to give rise to cNK/ILC1 cells (NK1.1+
NKp46+ T-bet+ EOMES+/−), ILC2 (NK1.1− NKp46− GATA-
3+ ROR𝛾t−), and ILC3 (NK1.1− NKp46− GATA-3− ROR𝛾t+),
showing that their differentiation potential was not affected
byCXCR6-deficiency (Figure 2(d)).This increase inCXCR6+
precursors was not due to a particular proliferative behavior
of bone marrow precursors in CXCR6-deficient conditions.
The lymphoid precursor subsets display similar frequency
of both Ki67+ and DAPI+ cells in CXCR6-deficient and
competent bone marrow (Figures 2(e) and 2(f)).
Overall, our results show that, in CXCR6-deficient mice,
a fraction of ILC precursors that still expresses GFP but
no functional CXCR6 protein under the control of Cxcr6
promoter is retained in the bonemarrow.This confinement to
the bone marrow concerns both ILCP and committed ILC2P
and indicates that CXCR6 contributes to cell egress of all ILC
subsets from the bone marrow.
3.2. CXCR6 Contributes to Fetal ILC3 and ILC3 Precur-
sor Circulation. Our previous work has shown that fetal
ILC3 precursors were found during embryonic development
in the fetal liver (FL) at embryonic day E15.5, among
CXCR6 expressing progenitors [14]. Similarly, to address
the contribution of CXCR6 to ILC3 circulation during
embryonic development, we analyzed E15.5 FL for the ILC3
precursor compartment, defined as Lin− c-Kit+ IL-7R𝛼+
ROR𝛾t+ (Figure 3(a)) in Cxcr6+/+ (wt), Cxcr6Gfp/+ (HZ), or
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Figure 1: ILCP and ILC2P in the bone marrow heterogeneously express CXCR6. (a) Flow cytometry of lineage depleted (Lin: CD3𝜀,
CD5, CD8, CD11c, CD19, TCR𝛽, TCR𝛾𝛿, Ter119, Gr1, and NK1.1) adult bone marrow (BM) from Cxcr6Gfp/+ Id2Yfp/+ mice. Among Lin− IL-
7R𝛼+ compartments are defined: CLP (filled gray, c-Kitlo Sca-1−/lo Flt3+ 𝛼
4
𝛽
7
−), ILCP (red, c-Kitlo Sca-1−/lo Flt3− 𝛼
4
𝛽
7
+), and ILC2P (blue,
c-Kit− Sca-1hi). Each compartment is analyzed for CXCR6-GFP and ID2-YFP expression (bottom histograms). (b) Cell culture of BM ILCP,
selected as ID2+ CXCR6− (upper panels) or ID2+ CXCR6+ (lower panels). Each population is sorted and cultured at 20 cells per well on OP9-
DL4 stromal cells with IL-7, c-KitL, and Flt3L for 10 days and analyzed by flow cytometry. Indicated obtained progenies were analyzed for
ID2-YFP, CXCR6-GFP, ROR𝛾t, and IL-7R𝛼 expression. Results are representative of at least 3 experiments each ((a): 𝑛 > 5), or 2 experiments
((b), at least 4 wells of each condition).
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Figure 2: CXCR6-deficient precursors are retained in the bone marrow. (a) Percentages in Lin− (upper panels) and absolute numbers (lower
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flow cytometry. Indicated obtained progenies were analyzed for T-bet, EOMES, ROR𝛾t, and GATA-3 expression. (e) Histograms of BM LSK
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red square), or Cxcr6Gfp/Gfp (KO, green triangle) adult mice. Data are representative of at least 3 experiments ((b), (e): 𝑛 > 5), or are from one
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𝑝 < 0.01; ∗∗∗𝑝 < 0.005).
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Figure 3: CXCR6 contributes to fetal ILC3 and ILC3 precursor circulation. (a) Flow cytometry of lineage depleted (Lin: CD3𝜀, CD11c,
CD19, Ter119, Gr1, NK1.1) E15.5 fetal liver (FL). ILC3 precursors are defined as Lin− IL-7R𝛼+ c-Kitmed ROR𝛾t+. (b) Percentages of Lin− IL-
7R𝛼+ c-Kitmed (left panel) and absolute numbers (right panel) of FL ILC3 precursors as defined in Figure 2(a) in FL from Cxcr6+/+ (wt,
blue losange), Cxcr6Gfp/+ (HZ, red square) or Cxcr6Gfp/Gfp (KO, green triangle) E15.5 embryos. (c) Flow cytometry of Lin− compartment fetal
spleen (FS) from Cxcr6Gfp/+ E15.5 embryos. Lin− CD4hi IL-7R𝛼+ cells (red) and total Lin− cells (filled gray) are analyzed for CXCR6-GFP
(left histogram) and ROR𝛾t (right histogram). (d) Scheme depicting injection and reconstitution experiment. (e) Analysis of reconstitution
experiment. 1000 to 2000 Ly5.2 Lin− CD4hi IL-7R𝛼+ CXCR6+ cells were injected in nonlethally irradiated Rag2−/−𝛾c−/− Ly5.1 mice. Recipients
were killed 4 weeks after injection and intestinal lamina propria (LP, upper panels) and liver (LV, lower panels) were analyzed by flow
cytometry. (f) Percentages of reconstitution experiment as explained in Figures 2(d) and 2(e) usingCxcr6Gfp/+ (HZ, red squares) orCxcr6Gfp/Gfp
(KO) E15.5 embryos in intestinal LP (left panel) or LV (right panel). Results are representative of at least 3 experiments each ((a), (c): 𝑛 > 5),
or are from 3 pooled experiments ((b), wt: 𝑛 = 6, HZ: 𝑛 = 10, KO: 𝑛 = 4), or are from at least 2 pooled experiments ((e), (f), LP HZ: 𝑛 = 2, LP
KO: 𝑛 = 5, LV HZ: 𝑛 = 4, LV KO: 𝑛 = 5). In ((b), (f)), each dot represents a single mouse. Statistical data are displayed with mean and SEM
(Student’s unpaired bilateral test, ∗𝑝 < 0.05; ∗∗𝑝 < 0.01).
Cxcr6Gfp/Gfp (KO) E15.5 FL (Figure 3(b)). We show that fre-
quencies of ILC3 precursors and absolute numbers were sig-
nificantly reduced, though not totally absent, in KO embryos
compared to both HZ and wt embryos (Figure 3(b)).
We next addressed directly the circulation capacities
of such CXCR6 expressing ILC3 precursors during adult
life. Fetal spleen (FS) Lin− CD4hi IL-7R𝛼+ cells are highly
enriched in CXCR6 expressing cells and are almost all
ROR𝛾t+ (Figure 3(c)). Among those cells, we purified the
CXCR6+ fraction from either Cxcr6Gfp/+ or Cxcr6Gfp/Gfp
Ly5.2 embryos and injected them into nonlethally irradiated
Rag2−/−𝛾c−/− Ly5.1 mice. Reconstitution for ILC1 and ILC3
compartments in the intestinal lamina propria (LP) and
liver (LV) was analyzed 4 weeks after injection (Figure 3(d)).
Among donor CD45.2+ cells, LP is mainly composed of
NK1.1− IL-7R𝛼+ ROR𝛾t+ ILC3 cells, whereas LV mainly
reconstitutes NK1.1+ IL-7R𝛼− ILC1 cells (Figure 3(e)). Inter-
estingly, all reconstituting cells expressed high levels of
CXCR6.We clearly observe that CXCR6-deficient progenitor
cells fail to reconstitute peripheral compartments, as com-
pared to Cxcr6Gfp/+ injected ILC3 precursors (Figure 3(f)).
In conclusion, CXCR6 highly contributes to fetal ILC3
precursors and ILC3 circulation, especially towards the intes-
tine and the liver.
3.3. Intestinal ILC Compartments Have Heterogeneous Expres-
sion of CXCR6 and Egress Markers. CXCR6 is heteroge-
neously expressed by ILC subtypes. By analyzing Rag2−/−
Cxcr6Gfp/+ intestinal LP, we show that ILC1 are all CXCR6hi
and the diverse ILC3 subsets express different levels of
CXCR6, with LTi-like cells expressing lower levels than
NCR+ and NCR− ILC3 subsets. In contrast, cNK are all
CXCR6−, and intestinal ILC2 subsets were separated into a
large CXCR6− and a smaller CXCR6+ fraction (Figure 4(a)).
We further analyzed expression of egress or retention
markers such as CD62L, CD69, and CD44, as well as CXCR6
and integrin 𝛼
4
𝛽
7
in intestinal LP and also mesenteric lymph
nodes (mLN) ILC populations (Figures 4(b) and 4(c)). All
ILC subsets expressed CD44 in all organs. Most of the
CD62L+ mLN cells belong to the ILC1-cNK subset. In the
LP, these cells largely become CD62L− as their ILC2 and
ILC3 intestinal counterparts. Only intestinal ILC2 subsets
were CD69lo, whereas intestinal ILC1-cNK and all ILC3
subsets were CD69+, suggesting less retention of ILC2 cells
in the tissue [21, 22]. In contrast, all mLN ILC subsets were
CD69−. CXCR6-GFP expression pattern in mLN ILC subsets
is similar to what could be observed in LP ILC subsets
(Figure 4(a)). Finally, integrin𝛼
4
𝛽
7
was only detected in ILC2
subset but not in other ILC subsets in both LP and mLN
(Figure 4(c)).
In conclusion, only intestinal ILC1 and ILC3 subsets that
express high levels of both CXCR6 and CD69 are more likely
to be tissue resident ILC populations.
3.4. Normal Intestinal ILC1 and ILC3 Compartments in
CXCR6-Deficient Mice Are Compensated by Higher Prolif-
erative Capacities of Respective ILC Compartments and of
an In Situ Progenitor Cell. We confirmed that, in CXCR6-
deficient mice, there was no impact on the repartition of the
different ILC subsets at homeostasis, except for cNK-ILC1
that are significantly (but slightly only) increased in CXCR6-
deficient LP (Figure 5(a)), in line with previous publications
[16]. Overall, the balance of intestinal ILC subsets was not
majorly affected, as we observed similar repartitions between
wt, HZ, and KOmice. Intestinal ILC are mainly composed of
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Figure 4: Intestinal ILC compartments have heterogeneous expression of CXCR6 and egress markers. (a) Flow cytometry of Lin−
(Lin: CD3𝜀, CD5, CD8, CD11c, CD19, TCR𝛽, TCR𝛾𝛿, Ter119, and Gr1) adult intestinal LP from Rag2−/− Cxcr6Gfp/+ mice. ILC
subsets are defined as cNK (filled gray, Lin− NK1.1+ NKp46+ IL-7R𝛼−), ILC1 (blue, Lin− NK1.1+ NKp46+ IL-7R𝛼−), ILC2 (red,
Lin− NK1.1− Thy1.2−/lo Sca-1hi c-Kit− ICOShi), ILC3 NCR+ (green, Lin− NK1.1− Thy1.2hi Sca-1−/lo c-Kit− NKp46+), ILC3 NCR− (orange,
Lin− NK1.1− Thy1.2hi Sca-1−/lo c-Kitmed NKp46+ CD4−), and LTi-like (light blue, Lin− NK1.1− Thy1.2hi Sca-1−/lo c-Kitmed NKp46+ CD4+).
Each compartment is analyzed for CXCR6-GFP expression. (b) Flow cytometry of Lin− adult intestinal LP from Rag2−/− Cxcr6Gfp/+mice. ILC
subsets are defined as ILC2 (red, Lin− GATA-3+ ROR𝛾t−), ILC3 NCR+ (green, Lin− GATA-3− ROR𝛾t+ NKp46+ CD4−), ILC3 NCR− (orange,
Lin− GATA-3− ROR𝛾t+ NKp46− CD4−), LTi-like (light blue, Lin− GATA-3− ROR𝛾t+ NKp46− CD4+), and ILC1-cNK (blue, Lin− GATA-3−
ROR𝛾t− NKp46+ NK1.1+). (c) Histograms depicting levels of CD62L, CD69, CD44, CXCR6-GFP, and 𝛼
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in Lin− (filled gray) or ILC subsets
(as defined in Figure 3(b)) in adult LP (upper panels) or mesenteric lymph nodes (mLN, lower panels) from Rag2−/− Cxcr6Gfp/+ mice. Results
are representative of at least 3 experiments each ((a), (b), (c): 𝑛 > 5).
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Figure 5: Normal intestinal ILC compartments in CXCR6-deficient mice are compensated by higher proliferative capacities of in situ
progenitor cell. (a) Percentages of ILC subsets in Lin− (as defined in Figure 3(b)) in adult LP from Rag2−/− Cxcr6+/+ (wt, blue losange),
Cxcr6Gfp/+ (HZ, red square), orCxcr6Gfp/Gfp (KO, green triangle) adult mice. (b) Histograms depicting levels of CD62L, CD69, CD44, CXCR6-
GFP, and 𝛼
4
𝛽
7
in Lin− (filled gray) or ILC subsets (as defined in Figure 3(b)) in adult LP (upper panels) or mesenteric lymph nodes (mLN,
lower panels) from Rag2−/− Cxcr6Gfp/Gfp mice. (c) Histograms of total LP Lin− cells (filled gray) or ILC2 cells (red line) for Ki67 expression and
DAPI levels. ((d), (e)) Percentages of Ki67+ cells (d) and DAPI+ cells (e) among ILC subsets (as defined in Figure 4(b)) in LP from Rag2−/−
Cxcr6+/+ (wt, blue losange), Cxcr6Gfp/+ (HZ, red square), or Cxcr6Gfp/Gfp (KO, green triangle) adult mice. (f) Flow cytometry of LP in situ ILCP
(upper panel) and CXCR6-GFP and ID2-YFP expression of LP in situ ILCP (lower panels) from Cxcr6Gfp/+ Id2Yfp/+ mice. (g) Percentages of
IL-7R𝛼+ precursors in Lin− (left), Ki67+ (middle), and DAPI+ (right) cells among IL-7R𝛼+ precursors in LP from Rag2−/− Cxcr6+/+ (wt, blue
losange), Cxcr6Gfp/+ (HZ, red square), or Cxcr6Gfp/Gfp (KO, green triangle) adult mice. Results are from 3 pooled experiments ((a), (c), (d): wt:
𝑛 = 9, HZ: 𝑛 = 9, KO: 𝑛 = 8) or from 2 pooled experiments ((e), (f), GF, wt: 𝑛 = 8, HZ: 𝑛 = 8, KO: 𝑛 = 6) or are representative of 3 experiments
(b). In ((a), (d), (e), (g)), each dot represents a single mouse. Statistical data are displayed with mean and SEM (Student’s unpaired bilateral
test, ∗𝑝 < 0.05; ∗∗𝑝 < 0.01).
45% to 50% of ILC3 (with a minority of 2% of LTi-like cells,
roughly 15% of ILC3 NCR+ cells, and mainly ILC3 NCR−
cells), then a subsequent part of ILC2 (10%), and a minority
of cNK-ILC1 cells (3% to 4%) (Figure 5(a)).
Similar to HZ mice, we tested CD69, CD62L, CD44,
CXCR6-GFP, and integrin 𝛼
4
𝛽
7
expression among ILC sub-
sets in LP and mLN from KO mice. We show that the
expression pattern of those markers was not significantly
perturbed by CXCR6-deficiency (Figure 5(b)).
Then, we tested whether each of the ILC subsets was
similarly distributed between the different stages of prolifer-
ation (Figure 5(c)). We defined that there was an important
increase (up to two fold increase) in Ki67+ cells amongst
cNK-ILC1 and all ILC3 subsets betweenHZ or wt control and
CXCR6-deficient conditions (Figures 5(c) and 5(d)). In con-
trast, the Ki67+ frequency of ILC2 cells remained unchanged.
Additionally, DAPI staining showed that all ILC subsets were
enriched in cells that were in S-G2-M stages (i.e., DAPI+)
in the CXCR6-deficient condition (Figure 5(e)).These results
show that intestinal ILC1 and ILC3 compartments, and to a
certain extent ILC2, were seeded with dividing DAPI+ and
active recently divided Ki67+ cells, after CXCR6 ablation.
We analyzed the putative in situ intestinal ILC precursor
fraction that is isolated as Lin− NKp46− NK1.1− GATA3−
ROR𝛾t− IL-7R𝛼+ cells (Figure 5(f)).This fraction, gated using
surrogate markers as described to identify ILC subsets in
Cxcr6Gfp/+ Id2Yfp/+mice (as in Figure 4(a)), expresses CXCR6
and ID2 (Figure 5(f)). No difference in the frequency of those
cells is observed, but they were significantly enriched in both
Ki67+ (active G1-S-G2 cells) and DAPI+ (dividing S-G2-M
cells) in CXCR6-deficient intestines (Figure 5(g)). This result
determines that this compartment is highly active in the
CXCR6-deficient mice and contributes to proliferation, thus
differentiation to seed the respective mature ILC compart-
ments.
In conclusion, these results show that in situ intestinal
ILC precursor cells compensate a defect in homing to the
intestine by homeostatically proliferating and result in a
proper balance of diverse ILC compartments.
4. Discussion
ILCs share numerous characteristics with the T-helper cell
subsets andwe considered that theymight have similarities in
their trafficking features even if they do not have to encounter
antigen. For na¨ıve T lymphocytes, it was demonstrated that
the intestinal homing marker 𝛼
4
𝛽
7
is upregulated after their
activation in themLN [23]. For the ILC lineage, this intestinal
homing marker is already expressed by their precursors in
the bone marrow. Moreover, CXCR6 was also shown to be
expressed by the most mature fraction of 𝛼
4
𝛽
7
+ medular
ILC precursors. Hence, CXCR6 may represent one of the
chemokine receptors important for the egress and homing
of ILC precursors. We decided to study the role of CXCR6
by comparing diverse features of ILC populations between
Cxcr6Gfp/+ and Cxcr6Gfp/Gfp mice in steady state conditions.
We crossed our mouse models to obtain Rag2−/− Cxcr6Gfp/+
and Rag2−/− Cxcr6Gfp/Gfp mice since most studies of ILC
function count on Rag2−/− mice to avoid an important
contamination of T cells.
The determination of CXCR6 expression fractions among
the ID2+ ILC precursors was performed using Cxcr6Gfp/+
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Id2Yfp/+ double reportermice and showed that the ILCP (Lin−
IL-7R𝛼+ Sca-1−/lo c-Kitmed Flt3− 𝛼
4
𝛽
7
+) and ILC2P (Lin−
IL-7R𝛼+ Sca-1hi c-Kitlo) subsets are inversely enriched into
CXCR6+ precursors, with fewCXCR6+ cells among ILCP and
a substantial fraction of CXCR6+ cells among ILC2P.
Here, we showed that deficiency of the chemokine recep-
tor CXCR6 leads to increased number of all bone marrow
CXCR6-GFP ILC precursors in homeostatic conditions.This
observation suggested that CXCR6 could either regulate
the proliferation of ILCP/ILC2P or could be implicated in
the egress of those precursors to the peripheral organs.
Hence, we analyzed the proliferative status of the bone
marrow progenitors and demonstrated that CXCR6 is not
implicated in the proliferation of these progenitor pools
but participates in their specific egress. Thus, we further
analyzed how the CXCR6 expression affects the steady-state
number of the different ILC subsets in vivo in the periphery.
Intestinal lamina propria was analyzed for the repartition
of the different ILC compartments in absence of CXCR6.
Despite the retention of ILC precursors in the bone marrow,
we observed comparable frequencies for mature ILC2 and
ILC3 intestinal subsets between Rag2−/− Cxcr6Gfp/+ and
Rag2−/− Cxcr6Gfp/Gfp littermates. Hence, under homeostatic
conditions, the deficiency in CXCR6 does not affect the
distribution of ILC2 and ILC3 subsets in the intestine as also
recently shown using CXCR6-deficient mice [16].
The absence of difference in ILC frequencies, at steady
state, suggested that CXCR6 was not required for the devel-
opment or tissue homing of ILC [16]. However, since we
observed that the ILC precursors are partially retained in the
bone marrow and previously showed their homing to the
periphery for final differentiation towards the ILC3 lineage
[14], we suspected CXCR6 as a specific chemokine receptor
for initiating the ILCP egress and homing. Then, we decided
to check for the seeding and frequency of this progenitor
compartment in the periphery. No decrease in the frequency
of this progenitor was observed. By analyzing its homeostatic
in situ proliferation, we proved that increased proliferation
of this progenitor in the intestine is one explanation for the
normal distribution of ILC subsets in CXCR6-deficient mice
despite the partial bone marrow retention.
We also used the combination of Ki67/DAPI to examine
the mature ILC subsets and showed that, in CXCR6-deficient
mice, all ILC subsets are more frequent in proliferation or
in active state in the intestine. ILC subsets in the intestinal
LP were already shown to be more activated than ILCs in
other tissues, probably because of their constant exposure to
varied environmental signals [24]. The analyses of intestinal
Ki67+ ILC subsets demonstrated that both recent prolifera-
tive ILC1 and ILC3 subsets stay in the intestine in CXCR6
deficient mice whereas ILC2 tends to leave the organ since no
increase of Ki67+ ILC2 cells was detected in CXCR6-deficient
intestines. This result is consistent with the observation that
intestinal ILC2 subsets express lower levels of the resident
marker CD69 and lower levels of CXCR6 than ILC3 subsets.
It has been previously shown that, in the intestinal lamina
propria, the diverse ILC3 subsets express CXCR6 at different
levels with higher levels for the NCR+ ILC3 subset [25]. We
found similar results in Rag2−/− Cxcr6Gfp/+ intestines where
the GFP expression is the highest in NCR+ ILC3 and in
most NCR− ILC3 cells and lower in both CD4+ LTi-like ILC3
and a small NCR− ILC3 subset. In infectious conditions,
a specific reduction of NCR+ ILC3 subset was shown in
CXCR6-deficient mice [25]. Indeed, Citrobacter rodentium
infection challenges have recently defined that CXCR6 may
highly contribute to the localization of NCR+ ILC3 subsets
and its capacity to eliminate the bacterial load. The CXCR6
ligand (CXCL16) is expressed in the intestine by a specific
population of CX3CR1+ DC cells [26] and was reported to
be crucial for NCR+ ILC3 stimulation and production of IL-
22 [25]. However, the regulation of ILC function could be
different depending on the ILC subset since numerous types
of cells, such as epithelial cells, monocytes, andmacrophages,
also express CXCL16.
CXCR6 is also important for circulation of ILC3 and
ILC3P in the embryo since we observed a significant decrease
of ROR𝛾t+ cells in the fetal liver of CXCR6-deficient mice.
We already assessed the effect of CXCR6 deficiency in ILC3
fetal differentiation and demonstrated that CXCR6deficiency
does not affect ILC3 differentiation during embryogenesis
[14]. Since Cxcr6Gfp/Gfp mice possess normal development
of Peyer’s patches and lymph nodes [14, 25], the homing
of ILC3P is not impaired. However, circulation of these
progenitors could be affected. Indeed, ROR𝛾t+ cells are rare
in the fetal liver and could be considered as partly derived
from the circulation. Hence, we suspected an important
role of CXCR6 for the recirculation of ILC3 precursors
and ILC3 subsets. We demonstrated by reconstitution assays
that, in absence of CXCR6 expression, ILC3P are unable to
correctly reach the peripheral organs contrary to CXCR6-
competent precursors. Reconstitutionswere performed using
i.v. injection suggesting that recirculation via the blood circuit
is altered in absence of CXCR6 expression.
A study using Kaede transgenic mice demonstrated a
constitutive trafficking of ILC from the gut to themLNwhere
LTi like-cells ILC3 migration was dependent on CCR7 in
contrary to other ILC subsets [27]. The predominance of
some ILC3 over other ILC subsets was already described
in LN and it was observed that, in lymphopenic mLN, the
ILC frequencies are altered [27], so we decided to look for
ILC homing markers expression in both CXCR6 competent
and deficient mLN but not for ILC respective repartition.
We found that markers are maintained after CXCR6 loss
and determined that ILCs were mainly trafficking between
the intestine and mLN since they were all CD44+ CD69− in
mLN. All ILC subsets except some ILC1 were clearly negative
for CD62L, showing no preferential circulation through
lymphoid organs.
In conclusion, we provide here new data on the role
of CXCR6 during circulation of ILC progenitors and ILC
populations at steady state. ILC precursors that are deficient
for CXCR6 are retained in the bone marrow and only few
of them could reach the blood and colonize peripheral
lymphoid organs to continue their maturation. However,
we demonstrated that homeostatic proliferation is increased
in these CXCR6 deficient animals to compensate for the
14 Mediators of Inflammation
reduction of seeding precursors resulting in normal ILC
subset distribution. Future studies concerning the function
of this receptor during inflammation and infection should
now take into account the importance of this receptor on ILC
recirculation capacities.
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